Association between dyslipidemia and CCL2 in patients undergoing hemodialysis

Wander Valadares de Oliveira Junior1, Ana Paula Ferreira Silva1, Roberta Carvalho de Figueiredo1

  • 1Campus Centro Oeste-Universidade Federal de São João Del-Rei, Brazil.

Cytokine
|September 27, 2019
PubMed

Insights

C-C Motif Chemokine Ligand 2 (CCL2) plasma levels are linked to dyslipidemia in hemodialysis patients. This finding suggests CCL2 may play a role in cardiovascular disease development for these individuals.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Immunology

Background:

  • Hemodialysis (HD) patients face elevated cardiovascular disease (CVD) risks, including heart attack, stroke, and heart failure.
  • C-C Motif Chemokine Ligand 2 (CCL2), also known as monocyte chemotactic protein-1 (MCP-1), is implicated in inflammatory processes and its levels increase in dyslipidemic chronic kidney disease (CKD) patients on HD.

Purpose of the Study:

  • To investigate the association between plasma C-C Motif Chemokine Ligand 2 (CCL2) levels and dyslipidemia in patients undergoing hemodialysis (HD).

Main Methods:

  • A cross-sectional study included 160 Brazilian HD patients.
  • CCL2 plasma levels were quantified using capture ELISA.
  • Linear regression analysis, adjusted for CVD risk factors, was employed to assess the association between CCL2 and dyslipidemia.

Main Results:

  • A statistically significant association was found between CCL2 plasma levels and dyslipidemia (P=0.029).
  • This association remained significant after adjusting for confounding variables like age, gender, BMI, diabetes, HD duration, and weight gain (P=0.045).

Conclusions:

  • Elevated CCL2 levels are associated with dyslipidemia in HD patients, suggesting a potential role for this cytokine in the pathogenesis of cardiovascular complications.
  • Further understanding of this mechanism could lead to novel therapeutic strategies to mitigate CVD in HD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
559
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
560
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.3K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.8K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
654